Imatinib
Orphan DrugFDA Approved
Contents
Description
Imatinib is a tyrosine kinase inhibitor used to treat certain cancers. It targets specific proteins that drive the growth of cancer cells. It is used in the treatment of inherited soft tissue tumors.
Indications & Therapeutic Use
Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumors (GIST), inherited soft tissue tumor
Linked Diseases:
Global Availability (4 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Imatinib — GNH India
239 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Bimatix
EU
Curevec
100mgcapsuleIndia
Gleevec
100 mg/1tabletUSA
Glipox
EU
Glivec
EU
Glivec 100
100mgtabletTurkey
Glivec 100mg
100mgtabletTurkey
Glivec 400mg
100mgtabletTurkey
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Imatinib
| Generic Name | Imatinib |
| Brands | 1 brand available |
| Active Ingredient | Imatinib mesylate |
| Drug Class | Chronic Myeloid Leukemia (CML) |
| Manufacturer | Novartis |
| Dosage Forms | Tablet |
| Medical Code | L01XE01 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00030689 |
| Countries | 4 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations5 Validated Nodes